PFHO Stock Pacific Health Care Organization (PFHO, $1.15) price exceeded its 50-day Moving Average on December 22, 2025

GET DAILY SIGNALS

Get AI intraday signals

PFHO - Pacific Health Care Organization, Inc.

Moving Avg. signal

View

Odds of DOWN Trend

Price: $1.15

Daily change: -$0.04 (-3.36%)

Daily volume: 4.4K

Capitalization: $14.7M

Industry: Managed Health Care

This price move could indicate a change in the trend, and may be a sell signal for investors. A.I.dvisor found 62 similar cases, and were successful. Based on this data, the odds of success are

PFHO's Stochastic Oscillator is remaining in overbought zone for 5 days

The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PFHO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PFHO entered a downward trend on December 15, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 16, 2025. You may want to consider a long position or call options on PFHO as a result. In of 117 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PFHO just turned positive on December 16, 2025. Looking at past instances where PFHO's MACD turned positive, the stock continued to rise in of 61 cases over the following month. The odds of a continued upward trend are .

PFHO moved above its 50-day moving average on December 23, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for PFHO crossed bullishly above the 50-day moving average on December 24, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 24 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where PFHO advanced for three days, in of 79 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PFHO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.293) is normal, around the industry mean (4.128). P/E Ratio (11.791) is within average values for comparable stocks, (34.771). PFHO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.225). PFHO's Dividend Yield (0.000) is considerably lower than the industry average of (0.023). PFHO's P/S Ratio (2.459) is very high in comparison to the industry average of (0.664).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.